The company delivered tremendous revenue growth but a deteriorating bottom line.
News & Analysis: 10x Genomics Inc
How much potential does this company have?
Here's why she likes them so much.
The genomics leader's process has evolved over time.
The company's technology is helping researchers understand the genetic underpinnings of the disease.
The company's technology is enabling researchers to explore single cells like never before.
The company's genomics technology was important in the research of these two diseases.
10x Genomics CEO Serge Saxonov thinks we're at the threshold of some big discoveries.
The company's CEO thinks it's capitalizing on the biggest value-creation opportunity of the next several decades.
10x Genomics' CEO identifies three key things to look for.